UVeyePRIVATE · FOUNDED 2016Each bar is the last disclosed mark — $467.19M for AliveCor (basis undisclosed, Aug 2022) and $100M for UVeye (basis undisclosed, Jul 2017).

UVeyePRIVATEOther · US · 2016
The $100M tells you…At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. Both are private: there is no public quote and no Canborsa market on either name.
AliveCor is valued at $467.2M, and UVeye at $100M.
AliveCor has raised $43.5M in total; UVeye has raised $295.5M.
AliveCor's lead investors include GE Healthcare, and UVeye's include Ahaka Capital.
AliveCor employs around 150 people; UVeye employs around 350.
AliveCor is headquartered in United States, and UVeye in United States.